These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7167540)

  • 1. Use of data from short-term tests in the evaluation of the carcinogenicity of environmental chemicals to humans.
    Yamasaki H; Wilbourn JD; Haroun L
    Prog Clin Biol Res; 1982; 109():169-80. PubMed ID: 7167540
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible use of short-term tests for carcinogens in experimental epidemiology.
    Stich HF; San RH; Lam P
    Natl Cancer Inst Monogr; 1977 Dec; 47():81-5. PubMed ID: 349403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal aberrations induced in rat lymphocytes by in vivo exposure to chemicals. A short-term method of carcinogenicity screening.
    Lilly LJ; Cobon AM; Newton MF
    Methods Find Exp Clin Pharmacol; 1979 Oct; 1(4):225-31. PubMed ID: 552588
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible methods of carcinogenicity testing for substances used at the place of work.
    Steinhoff D
    Cancer Detect Prev; 1981; 4(1-4):41-6. PubMed ID: 7349803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a technique for the rapid screening of chemicals for carcinogenicity [proceedings].
    Cobon AM; Lilly LJ; Newton MF; Hobbiger F
    Br J Pharmacol; 1978 Mar; 62(3):455P-456P. PubMed ID: 638372
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations, chromosome aberrations and cancer.
    Bishun N; Smith N; Williams D
    Clin Oncol; 1978 Sep; 4(3):251-63. PubMed ID: 750128
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytogenetic damage as an endpoint in short-term assay systems for detecting environmental carcinogens.
    Evans HJ; Ishidate M; Leng M; Miller CT; Mitelman F; Vogel E
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):227-44. PubMed ID: 6935181
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do we know what causes cancer.
    Shaw CR; Leal N
    Tex Rep Biol Med; 1978; 37():21-5. PubMed ID: 380044
    [No Abstract]   [Full Text] [Related]  

  • 10. The predictability of bioassays.
    Anderson D
    Prog Clin Biol Res; 1982; 109():149-68. PubMed ID: 6891964
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospects of short-term tests in primary cancer prevention.
    Khudoley VV; Pliss GB
    Neoplasma; 1984; 31(4):475-8. PubMed ID: 6472519
    [No Abstract]   [Full Text] [Related]  

  • 12. Limitations of metabolic activation systems used in short-term tests for carcinogens.
    Bigger CA; Dipple A
    Dev Toxicol Environ Sci; 1980; 8():171-4. PubMed ID: 6796372
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of short-term tests in detecting carcinogenicity of complex mixtures.
    Anderson D
    IARC Sci Publ; 1990; (104):89-100. PubMed ID: 2228146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapolation of animal studies to the human situation.
    Zapp JA
    J Toxicol Environ Health; 1977 Jul; 2(6):1425-33. PubMed ID: 886632
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationale for deployment of short-term assays for evidence of carcinogenicity.
    Drake JW; de Serres FJ; Darby WJ; Dunkel VC; Longfellow DG; Ott H; Purchase IF; Ramel C; Schlatter C; Smith EM
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):295-308. PubMed ID: 6935184
    [No Abstract]   [Full Text] [Related]  

  • 16. Animal-human studies: an integrated approach to identifying hazardous chemicals in the workplace.
    Legator MS; Harper BL
    Prog Clin Biol Res; 1982; 109():181-202. PubMed ID: 7167541
    [No Abstract]   [Full Text] [Related]  

  • 17. The scientific basis for short-term tests for carcinogenicity: non-mammalian systems.
    Green MH
    IARC Sci Publ; 1980; (27):155-67. PubMed ID: 7002777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term tests with biochemical end points relevant to the prediction of carcinogenic potential of drugs.
    Martin RA; de la Iglesia FA
    Drug Metab Rev; 1983; 14(3):513-55. PubMed ID: 6191938
    [No Abstract]   [Full Text] [Related]  

  • 19. Contemporary trends in in vivo and in vitro testing of chemical carcinogens.
    Slamenová D
    Neoplasma; 2001; 48(6):425-34. PubMed ID: 11949832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The necessity of determining the mutagenicity of new drugs].
    Bogajewski J; Schöneich J
    Pol Tyg Lek; 1982 Mar; 37(2):63-7. PubMed ID: 6750579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.